文献速递睡眠呼吸障碍咽喉与嗓音

舌下神经刺激治疗无应答者仍持续使用并获益

Hypoglossal Nerve Stimulation Usage by Therapy Nonresponders.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-08-10

本研究基于国际多中心前瞻性注册数据库,分析舌下神经刺激治疗阻塞性睡眠呼吸暂停(OSA)患者中应答者(R)与无应答者(NR)在治疗使用和结局上的差异。共纳入497例(69%)R和220例(31%)NR,NR组多数患者仍持续使用设备,并在氧减指数、Epworth评分及生活质量方面获得改善。

要点

  • NR组77%患者报告生活质量改善,R组为96%。
  • NR患者若自觉改善,应鼓励继续使用设备并联合其他策略降低OSA长期影响。

核心结论

  • 被归类为无应答者的患者仍持续使用舌下神经刺激治疗,并在氧减指数、日间嗜睡和生活质量方面获得改善。

研究设计与样本

  • 国际多中心前瞻性注册数据库分析(证据等级III),纳入舌下神经刺激治疗OSA患者,随访12个月。

主要发现

  • 共497例(69%)为应答者,220例(31%)为无应答者。
  • 应答者组每晚使用>4小时的依从性显著更好(P = .001)。
  • 应答者组平均每晚使用时长显著更长(P = .001)。
  • 应答者组最终Epworth评分显著更优(P = .001)。
  • 应答者组主观改善程度显著更高(P < .001)。

关键数值与推荐

  • 应答者定义采用Sher标准:12个月随访时最终呼吸暂停低通气指数(AHI)≤20且AHI降低>50%。

临床怎么用

  • 对自觉改善的无应答者应鼓励继续使用设备,并整合其他策略以降低OSA长期影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study is to examine differences in therapy usage and outcomes of therapy between responder (R) and nonresponder (NR) groups in an international, multicenter prospective registry of patients undergoing hypoglossal nerve stimulation for obstructive sleep apnea (OSA). STUDY DESIGN: Database analysis (level III). SETTING: International, multicenter registry. METHODS: The studied registry prospectively collects data pre- and postimplantation, including sleep parameters, Epworth score, patient experience, and safety questions, over the course of 12 months. Patients are defined as a "responder" based on Sher criteria, which require a final apnea-hypopnea index (AHI) of ≤20 and a final AHI reduction of >50% at their 12-month follow-up. RESULTS: Overall, there were 497 (69%) R and 220 (31%) NR. Most patients in both groups experienced improvement in quality of life following implantation (96% of R; 77% of NR) with reductions in oxygen desaturation index and Epworth score. At final follow-up, the R group demonstrated significantly better adherence to recommended therapy (>4 hours/night) (P = .001), average hours of nightly use (P = .001), final Epworth scores (P = .001), and degree of subjective improvement (P < .001). CONCLUSION: Patients classified as NR to upper airway stimulation continue to use therapy with improvement in percent time of sleep with O2 <90%, reduction in daytime sleepiness, and improvement in quality of life. Therefore, ongoing usage of the device should be encouraged in NR patients who note improvement while integrating additional strategies to lower the long-term effects of OSA.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Coca KK, Heiser C, Huntley C, et al. Hypoglossal Nerve Stimulation Usage by Therapy Nonresponders. Otolaryngol Head Neck Surg. 2021. PMID: 34372740. doi:10.1177/01945998211036867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。